About the Company
Shanghai Modern Pharmaceutical Co., Ltd. from Shanghai Institute of Pharmaceutical Industry as the main sponsor, the Joint National Engineering Research Center for Pharmaceutical Preparations, Shanghai Ruijin Hospital, Hiroji medical high-tech company's five co-sponsored enterprises and to market-oriented high-tech pharmaceutical companies.
The company in 1997 was assessed as high-tech enterprises in Shanghai and has been ma...
Shanghai Modern Pharmaceutical Co., Ltd. from Shanghai Institute of Pharmaceutical Industry as the main sponsor, the Joint National Engineering Research Center for Pharmaceutical Preparations, Shanghai Ruijin Hospital, Hiroji medical high-tech company's five co-sponsored enterprises and to market-oriented high-tech pharmaceutical companies.
The company in 1997 was assessed as high-tech enterprises in Shanghai and has been maintained so far, all the products and dosage forms all through the State Food and Drug Administration's GMP certification. June 16, 2004, Shanghai Modern Pharmaceutical Co., Ltd. A shares listed on the Shanghai Stock Exchange successfully issued, the securities code: 600.42 thousand, the securities referred to as: Modern pharmaceuticals. The company through the capital markets for the industrial operation and the best combination of capital operation, greatly forged and nurtured the company's core competencies and further strengthened the road of taking the technology industry's confidence.
August 2004, the modern pharmaceutical business Qiu Hasen Henan Pharmaceutical Holdings Limited, and renamed the Shanghai Modern Hassan (Shangqiu) Pharmaceutical Co., Ltd., complement and expand the company's production capacity of water injection. In May 2008, the modern pharmaceutical acquisition of a wholly-owned Shanghai Pharmaceutical Co., Ltd. Medical Engineering Institute to form R & D, production and marketing functions as a whole, with chemical raw materials, pharmaceutical preparations and bio-pharmaceutical products, the new high-tech pharmaceutical enterprises, under the 5 subsidiaries and 3 production bases. The company's size and profitability in the pharmaceutical industry in Shanghai, the top 10% of the column, and enter the Top 100 list of China's pharmaceutical enterprises.
Modern Pharmaceutical R & D center has been identified as Enterprise Technology Center in Shanghai, the company's R & D Center, Dr. 3, Master 16. The majority shareholder Shanghai Institute of Pharmaceutical Industry to have Chinese Academy of Engineering, two people, enjoy the special allowance of the State Council 68, National Center for Drug Evaluation Experts 12. Meanwhile, the Shanghai Pharmaceutical Industry Research Institute is an interdisciplinary doctorate in pharmacy to grant the right of units, has a pharmacy doctoral student in all disciplines, the field of training qualifications, and Shanghai Jiao Tong University build a "School of Pharmacy, Shanghai Jiao Tong University" to train master's and doctoral pharmaceutical field Health.
In the Chinese Academy of Engineering led by a strong scientific research, management, production team, led by the modern pharmaceutical active part in the production process level and the engineering skills enhancement, edge highlighting, impressive:
The modern pharmaceutical business is mainly engaged in domestic and the world's leading new types of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials and Chinese medicine formulations of the R & D, production and sales. Currently has chemical raw materials, biological and chemical raw material medicine, microbial fermentation products and tablets, capsules, granules, injections, suspensions, suppositories, and ointments such as product formulations. In the new preparation area, full use of new slow-release technology platform, so that many traditional varieties of fresh with new vitality; in the field of bio-pharmaceuticals, by virtue of a high-quality, high-level R & D team, through the representative of the international most advanced level of biological separation and purification Technology has won the market, the products are exported to overseas; in the field of chemical raw materials, through the process technology continues to enhance its market share to stay ahead.
Many products are included in the company's national "Ninth Five-Year" key scientific and technological projects, state-level torch plan project, the Shanghai Hi-tech achievement transformation project, the Shanghai Torch Program projects, and has repeatedly won the National Key New Product Award, Shanghai Science and Technology Achievement Award, Shanghai Excellent New Product Award, Shanghai and Shanghai Famous Brand famous quality products such as the pharmaceutical industry. The main products Azithromycin tablets, nifedipine controlled-release tablets, sustained-release capsules of cefalexin, cefaclor sustained-release capsule, enalapril maleate tablets, sustained-release suspension of dextromethorphan and azithromycin, zidovudine, Drospirenone, lipoic acid and other raw materials and other products have a high market share and visibility, best-selling overseas markets.
"Modern" trademark in 2007 was "Shanghai famous brand" title. The main brand "Shenkar ®", "Shen Luo ®", "Xiaomei ®", "PU Yue Qi ®", "Pu Rainbow ®", "pleased ®", "PU Hui-Zhi ®", "excellent Xin Zhi ® "," supporting sling ® "," Pu Xiu ® "and so on, in the domestic market enjoy a high reputation.
Shanghai Institute of Pharmaceutical Industry Group, established strategic goal is to become the leading high-tech pharmaceutical enterprise group, the modern pharmaceutical R & D as the group's own industrialization base for their own strategic goals have been identified, namely, research and innovation system formation and the Group of upstream and downstream co-operation process and to national "Eleventh Five-Year" special "Shanghai Modern Pharmaceutical Drug integrating innovative technology platform" and "the establishment of a process control of new drug formulations and process technology platform" as an opportunity to further enhance the results of scientific research and industrialization of their own transformation capacity, the formation of the modern pharmaceutical distinctive core competencies.
Market Place
